Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features:: differential requirements for the modulation of FGF-1 and FGF-2

被引:102
作者
Pye, DA
Vivès, RR
Hyde, P
Gallagher, JT
机构
[1] Univ Manchester, Christie Hosp,Paterson Inst Canc Res, CRC, Dept Med Oncol, Manchester M20 4BX, Lancs, England
[2] Univ Manchester, Christie Hosp,Paterson Inst Canc Res, CRC, Dept Drug Dev, Manchester M20 4BX, Lancs, England
关键词
heparan sulfate; oligosaccharides; FGF-1; FGF-2; activity;
D O I
10.1093/glycob/10.11.1183
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of heparan sulfate (HS) (and the closely related molecule heparin) with FGF-1 is a requirement for enabling the growth factor to activate its cell surface tyrosine kinase receptor. However, little is known about the regulatory role of naturally occurring cell surface us in FGF-1 activation. We have addressed this issue by utilizing a library of us oligosaccharides, which are defined in both length and sulfate content. Mitogenic activation assays using these oligosaccharides showed that us contained both FGF-1 activatory and inhibitory sugar sequences. Further analysis of these oligosaccharides showed a clear correlation between FGF-1 promoting activity and their 6-O-sulfate content. The results, in particular with the dodecasaccharide sequences, suggested that specific positioning of 6-O-sulfate groups may be required for the promotion of FGF-1 mitogenic activity. This may also be true for 2-O-sulfate groups though the evidence was not as conclusive. Differential activation of FGF-1 and FGF-2 was also observed and found to be mediated by both oligosaccharide length and sulfation pattern, with different specific O-sulfate positioning being implicated for the promotion of different growth factors. These results suggest that variation and tight control of the fine structure of us may allow cells to not only control their positive/negative responses to individual FGEs but also to change specificity towards promotion of different members of the FGF family.
引用
收藏
页码:1183 / 1192
页数:10
相关论文
共 88 条
[31]   STRUCTURAL REQUIREMENTS IN HEPARIN FOR BINDING AND ACTIVATION OF FGF-1 AND FGF-4 ARE DIFFERENT FROM THAT FOR FGF-2 [J].
ISHIHARA, M .
GLYCOBIOLOGY, 1994, 4 (06) :817-824
[32]   IMPORTANCE OF 6-O-SULFATE GROUPS OF GLUCOSAMINE RESIDUES IN HEPARIN FOR ACTIVATION OF FGF-1 AND FGF-2 [J].
ISHIHARA, M ;
TAKANO, R ;
KANDA, T ;
HAYASHI, K ;
HARA, S ;
KIKUCHI, H ;
YOSHIDA, K .
JOURNAL OF BIOCHEMISTRY, 1995, 118 (06) :1255-1260
[33]   Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro [J].
Jayson, GC ;
Lyon, M ;
Paraskeva, C ;
Turnbull, JE ;
Deakin, JA ;
Gallagher, JT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :51-57
[34]   AN ESSENTIAL HEPARIN-BINDING DOMAIN IN THE FIBROBLAST GROWTH-FACTOR RECEPTOR KINASE [J].
KAN, MK ;
WANG, F ;
XU, JM ;
CRABB, JW ;
HOU, JZ ;
MCKEEHAN, WL .
SCIENCE, 1993, 259 (5103) :1918-1921
[35]   EFFECT OF HEPARIN ON THE BINDING-AFFINITY OF ACIDIC FGF FOR THE CLONED HUMAN FGF RECEPTORS, FLG AND BEK [J].
KAPLOW, JM ;
BELLOT, F ;
CRUMLEY, G ;
DIONNE, CA ;
JAYE, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 172 (01) :107-112
[36]  
KATO M, 1994, J BIOL CHEM, V269, P18881
[37]   ISOLATION OF AN ADDITIONAL MEMBER OF THE FIBROBLAST GROWTH-FACTOR RECEPTOR FAMILY, FGFR-3 [J].
KEEGAN, K ;
JOHNSON, DE ;
WILLIAMS, LT ;
HAYMAN, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) :1095-1099
[38]   ANALYSIS OF AFFINITY AND STRUCTURAL SELECTIVITY IN THE BINDING OF PROTEINS TO GLYCOSAMINOGLYCANS - DEVELOPMENT OF A SENSITIVE ELECTROPHORETIC APPROACH [J].
LEE, MK ;
LANDER, AD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (07) :2768-2772
[39]   PURIFICATION AND COMPLEMENTARY-DNA CLONING OF A RECEPTOR FOR BASIC FIBROBLAST GROWTH-FACTOR [J].
LEE, PL ;
JOHNSON, DE ;
COUSENS, LS ;
FRIED, VA ;
WILLIAMS, LT .
SCIENCE, 1989, 245 (4913) :57-60
[40]   MORE TO HEPARIN THAN ANTICOAGULATION [J].
LINDAHL, U ;
LIDHOLT, K ;
SPILLMANN, D ;
KJELLEN, L .
THROMBOSIS RESEARCH, 1994, 75 (01) :1-32